Results 71 to 80 of about 20,434 (226)

The different face of skin‐rash induced by brentuximab vedotin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri   +11 more
wiley   +1 more source

Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides

open access: yes, 2023
Mycosis fungoides is the most common primary cutaneous T-cell lymphoma, characterized by skin-homing CD4+ T cells derivation, indolent course, and low-grade of malignancy.
Francesco Pastore   +25 more
core   +2 more sources

MYCOSIS FUNGOIDES [PDF]

open access: yesBritish Journal of Dermatology, 1901
n ...
openaire   +2 more sources

Diagnostic Accuracy of Dermoscopy and Trichoscopy in Mycosis Fungoides. A Systematic Review

open access: yes
Mycosis fungoides is the most common cutaneous T-cell lymphoma. The aim of this review is to assess the value of dermoscopy and trichoscopy in mycosis fungoides diagnosis.
Agnieszka Michalczyk   +6 more
core   +1 more source

Ropeginterferon‐α2b in mycosis fungoides and Sézary syndrome: Safety and efficacy in 41 patients

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Pegylated interferon‐α2a became the off‐label alternative for treating mycosis fungoides/Sézary syndrome (MF/SS) after non‐pegylated interferons were withdrawn. This study aimed to evaluate the safety and efficacy of ropeginterferon‐α2b in MF/SS. Patients and methods We performed a retrospective multicenter analysis at
Stefanie Porkert   +15 more
wiley   +1 more source

Mycosis Fungoides: A Case Report [PDF]

open access: yes, 2021
Mycosis fungoides is the most common primary cutaneous T-cell lymphoma and is recognized as one of the rare malignant skin neoplasms. Hypopigmented mycosis fungoides is a variant of mycosis fungoides, described in dark-skinned individual and Asian ...
Anisha Joshi, Deeptara Pathak Thapa
core  

High Expression of Fas/CD95 on CD4+ Circulating T Cells: An Exclusion Criterion in the Diagnosis of Mycosis Fungoides?

open access: yesActa Dermato-Venereologica, 2017
The aim of this 10-year monocentric prospective study was to determine a cut-off value of Fas/CD95 expression by peripheral blood CD4+ T lymphocytes in discriminating patients with mycosis fungoides from controls with cutaneous benign lymphocytic ...
Aurélie Du-Thanh   +5 more
doaj   +1 more source

Mycosis fungoides: a review [PDF]

open access: yesClinical and Experimental Dermatology
Abstract Mycosis fungoides (MF) is the commonest subtype of cutaneous lymphoma, characterized by the infiltration of malignant T-cell clones into the skin. It accounts for approximately 60% of all cutaneous T-cell lymphoma diagnoses.
Charlotte Sheern   +6 more
openaire   +2 more sources

Cutaneous lymphomas – an update

open access: yesHistopathology, EarlyView.
Primary cutaneous lymphomas and lymphoproliferative disorders are defined by integrated clinical, histopathological, immunophenotypic and genetic features as diagnostic criteria also in the 5th edition of the WHO classification of haematolymphoid tumors.
Werner Kempf, Christina Mitteldorf
wiley   +1 more source

Mycosis Fungoides [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1935
G B, Dowling, W, Freudenthal
openaire   +5 more sources

Home - About - Disclaimer - Privacy